Registered entities
Emulate Inc.
Reg. No. 464857430United States
EMULATE GERMANY
Reg. No. 0805.535.609Belgium
Innovation
44 patent families (40 granted) — focus: Chemistry & metallurgy, Operations & transport, Physics & computing, Mechanical engineering; filing pace slowing. Cited 5,670 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 13 |
| 2018 | 18 |
| 2019 | 27 |
| 2020 | 31 |
| 2021 | 28 |
| 2022 | 23 |
| 2023 | 27 |
| 2024 | 24 |
| 2025 | 8 |
Social engagement
Social engagement: 29.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
26 investors on record; lead investors include Cedars Sinai, OS Fund, ATEL Ventures, LabCorp.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 16 | 62% |
| Private equity | 3 | 12% |
| Other / undisclosed | 7 | 27% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
17 Jun 2026 · Business Development Executive · Northeast US, United States
14 Jul 2025 · Director of Software Engineering · Boston
14 Jul 2025 · Director of Software Engineering Emulate, Inc. · Boston
Based on job postings tracked across public sources.
Recent activity
18 Jun 2026
Event
BIO2026 panel discussion on NAM adoption
17 Jun 2026
Event
Organ-on-a-Chip technology presentation
11 Jun 2026
Event
Lung Alveolus-on-a-Chip model webinar
